Home/Filings/4/0001140361-11-003589
4//SEC Filing

Bencherif Merouane 4

Accession 0001140361-11-003589

CIK 0001124105other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 5:40 PM ET

Size

18.3 KB

Accession

0001140361-11-003589

Insider Transaction Report

Form 4
Period: 2011-01-18
Bencherif Merouane
VP, Preclinical Research
Transactions
  • Exercise/Conversion

    Common Stock

    2011-01-18$5.55/sh+22,800$126,54022,800 total
  • Sale

    Common Stock

    2011-01-19$27.09/sh30,203$818,2570 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-01-197,9510 total
    Exercise: $5.55Exp: 2016-08-15Common Stock (7,951 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-01-1922,2520 total
    Exercise: $1.75Exp: 2013-10-30Common Stock (22,252 underlying)
  • Exercise/Conversion

    Common Stock

    2011-01-19$5.55/sh+7,951$44,1287,951 total
  • Sale

    Common Stock

    2011-01-18$27.17/sh22,800$619,4760 total
  • Exercise/Conversion

    Common Stock

    2011-01-19$1.75/sh+22,252$38,94130,203 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-01-1822,8007,951 total
    Exercise: $5.55Exp: 2016-08-15Common Stock (22,800 underlying)
Footnotes (4)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.69 to $27.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]This option vested in installments and became vested and exercisable in full on June 30, 2010.
  • [F4]This option vested in installments and became vested and exercisable in full on September 30, 2007.

Documents

1 file

Issuer

TARGACEPT INC

CIK 0001124105

Entity typeother

Related Parties

1
  • filerCIK 0001295831

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:40 PM ET
Size
18.3 KB